YI logo

111 INC

YINASDAQ
πŸ† #3852 by market capEarnings Aug 20US Equity
$133.77β–² $10.70 (+8.00%)
Simulated price
1hβ€”
24hβ–² 8.0%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$5M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-20.9%
Declining
πŸ“ŠGross Margin
5.8%
Thin
πŸ’΅FCF Margin
1.6%
Thin
βš–οΈP/S Ratio
0.0x
Cheap
Otter Score
65
Fair
No chart data available for YI.

Trading Snapshot

Day Range
$133.26 – $136.38
52-Week Range
β€”
Volume
$2.81B
Avg Volume
$2.04B
Shares Outstanding
175.9M
Next Earnings
Sep 23, 2026

Fundamentals Snapshot

Annual Revenue
$12.21B
Last Q Revenue
$2.36B
P/E Ratio
β€”
P/S Ratio
0.0x
EPS (TTM)
β€”
Dividend Yield
β€”

Why Investors Own YI

  • βœ“High-growth profile β€” revenue up +29.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 57% gross margin and 19% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$12.21Bβ–² +33.5% YoY
Gross Margin (TTM)
57.1%β–² +2.0% YoY
Operating Income (TTM)
$3.59Bβ–² +33.5% YoY
Free Cash Flow (TTM)
$2.30Bβ–² +33.5% YoY

About 111 INC

Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
65/100

Analyst Price Target

β“˜
Average Target
$132.75
β–Ό βˆ’0.8% Downside
High Target$158.18
Low Target$110.13
Based on 17 analysts

Latest News & Updates